logo
[breadcrumb_custom]

Category: Trading Signals

Trading Signals

What Caused Motus GI (MOTS) Stock to Rise Nearly 40%?

The stock price of Motus Holdings Inc. (NASDAQ: MOTS) rose 40.42% to $2.64 in current trading after a new patent was issued a few hours ago. MOTS stock closed the last session at $1.88. MOTS has received which patent? A new patent titled, “Cleaning Method for Prepless Colonoscopy,” has been issued to Motus GI (MOTS) by the United States Patent and Trademark Office (USPTO). Using the Pure-Vu System, Mutus GI can clear the colon in patients who have had little or no preparation before their colonoscopy. Physicians may be able to achieve maximum visualization for all patients while avoiding standard

Trading Signals

What Led The SAI.TECH (SAI) Stock To Increase After-Hours On Thursday?

The stock of SAI.TECH Global Corporation (NASDAQ: SAI) rose 49.56% in after-hours trading to close at $3.38 after announcing new products and lost -26.14 percent during regular trading. What products has SAI launched? As part of its SAIHUB BOX product line, SAI.TECH (SAI) announced this week the addition of two new products, the TANKBOX and RACKBOX. The TANKBOX and RACKBOX are both designed with separate immersion cooling and plate cooling technologies, making them adaptable to any outdoor installation environment and compatible with all current mining models. SAIHUB-CAB The SAIHUB CAB is the first generation of SAIHUB’s indoor cabinet products. It

Trading Signals

Top-notch Stock to Watch: Kinsale Capital Group Inc. (KNSL)

Kinsale Capital Group Inc. (NYSE: KNSL) shares have increased in value by more than 44% in the last year. This is higher than the industry’s average growth rate during the same time period. A KNSL share cost $261.8 5 in the August 30 trading. Kinsale Capital Group Inc. (KNSL) is unique in that it works in the market of insurance for subtle risks, with a focus on excess and supplemental insurance products (E&S). This insurance is chosen to cover hazards that are not covered by traditional insurance plans. The firm often produces unique policies with a greater rate of return

Trading Signals

Top-notch Stock to Watch: The Trade Desk Inc. (TTD)

The advertising platform The Trade Desk Inc. (NASDAQ: TTD) revealed second-quarter earnings this week that exceeded Wall Street’s expectations. Furthermore, despite widespread bad tendencies in the advertising industry, the firm grew. Several major advertising platforms have reported decreases in advertiser spending in recent months. As a result, Wall Street analysts did not anticipate big returns from Trade Desk. However, the company’s revenue increased 35% year on year to $377 million. The client retention rate was around 95%, and the total number of customers was approximately 1,000. In the second quarter of 2022, adjusted EBITDA climbed by nearly 18% to $139

Trading Signals

Cannabis Stocks to Watch in 2022

Companies involved in the cannabis industry work on developing, manufacturing, and distributing cannabis products, as well as companies that support them indirectly. Growing numbers of regions around the world are legalizing cannabis, which has made traditional stock market indices like the NASDAQ include more companies in this industry. There is an expectation that the cannabis industry will grow by at least 25% every year by 2030, and investors are eager to take advantage of the growth. Businesses and entrepreneurs are increasingly capable of taking advantage of cannabis decriminalization or legalization, particularly in states and countries that have already decriminalized or

Trading Signals

Is Alphabet Inc. (GOOGL) Still Worth A Bite?

This week, Alphabet Inc. (NASDAQ: GOOGL) will split its shares, making it available to a broader variety of ordinary investors. Could this be the start of a new upward trend? After the conclusion of trade on Friday, July 15, there will be a share split in the ratio of 20 to 1. In that instance, a share worth around $2300 will be divided into 20 shares at approximately $115. Obviously, such a price is far more feasible for many investors who could previously only acquire one share of Alphabet Inc. (GOOGL) and only through particular investing programs. Furthermore, investors will

Trading Signals

Highlights from the Financial Report for Accenture plc (ACN)

Accenture plc (NYSE: ACN), a consulting and outsourcing corporation, exceeded Wall Street analysts’ projections for revenue growth in the most recent quarter. Despite that, the company’s quarterly results were below expectations, causing it to decrease its earnings forecast for the remainder of the year. Accenture’s sales increased by 22% to more than $16 billion in the third quarter of fiscal 2022. The amount of net income rose by 15% to $1.79 billion, or $2.79 per share, which was a little less than Wall Street experts had predicted. Revenue increase was seen across the board for the company’s activities, including product

Trading Signals

Getting Sustainable Earnings? Couchbase, Inc. (BASE)

Couchbase, Inc. (NASDAQ: BASE), a database technology provider, released a positive report for the first quarter of fiscal 2023. The company reports double-digit growth in revenue and s expects further revenue growth. and cloud computing. For the quarter ended April 30, Couchbase, Inc. (BASE) grew 25% year-over-year to $34.9 million, with subscription sales up 21% to 32 USD and a 27% increase in recurring revenue. Operating loss increased to $19 million. Cash flow from operations increased to $8.6 million from $3.2 million a year earlier. Couchbase, Inc. (BASE) has added a new DBaaS (database subscription) service to Google Cloud, capitalizing

Trading Signals

Eli Lilly and Company (LLY) Becomes Attractive Again

Eli Lilly & Company (NYSE: LLY) has won clearance to market tirzepatide, a medicine that has the potential to change diabetes treatment. On May 17, LLY stock rose 2.66 percent to $299.38 in trading. Experts from the US Food and Drug Administration (FDA) agreed that tirzepatide is sufficiently effective and safe for therapeutic usage based on the findings of the third phase of clinical research. The medicine reduced blood sugar levels more effectively than currently available medications.  Eli Lilly gained authorization to commercialize tirzepatide as an addition to a healthy diet and physical activity program for persons with type 2

Trading Signals

Qualcomm Incorporated (QCOM) is Gaining Momentum on Earnings Catalyst

Qualcomm Incorporated (NASDAQ: QCOM) has released its second-quarter report for the fiscal year 2022. The stock surpassed Wall Street projections by a wide margin, and its stellar performance was one of the driving forces behind the tech sector’s rally on April 28. Qualcomm’s sales increased 41% year over year to a new high of $11.2 billion, with GAAP earnings of $2.57 per share. The corporation paid out $1.7 billion in dividends to stockholders, including $0.8 billion in dividends. Despite transitory supply chain difficulties, Qualcomm’s business remains robust and healthy. Sales are increasing in all main areas, and revenue is expected